This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioPharm America
BioPharm America is merging with LSX USA
Hynes Convention Center | Boston, MA

September 11–12, 2024

Ryan O'Quinn
Partner at Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Speaker

Profile

Ryan O’Quinn, PhD, partner in Finnegan, Henderson, Farabow, Garrett & Dunner, LLP’s Reston office, maintains a versatile practice focusing on U.S. district court patent litigation, post-grant proceedings at the U.S. Patent and Trademark Office (USPTO), patent prosecution, and portfolio management and counseling. Ryan’s practice covers a range of technologies, including pharmaceuticals, biotechnology, immunotherapy, medical devices, computer software, business methods, vending technologies, and mechanical systems. Ryan has litigation and counseling experience in small molecule drugs, biologics, and nucleic acid compositions, and helps clients large and small manage procurement and licensing of their multi-national patent portfolios. Ryan has a law degree from Duke University, a PhD in biology from the University of North Carolina at Chapel Hill, and a BS in biomedical engineering from North Carolina State University.

Agenda Sessions

  • Global investment, diverse portfolios, and partnering across borders

    2:30pm